EGF Theramed Health Corp.
TMED
Rank in Stocks
#39125
EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to... EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.
Share Price
$0.05137558
Last synced: 2026-06-26
Market Cap
$596.81K
Change (1 day)
0.00%
Change (1 year)
-32.40%
Country
CA
Trade EGF Theramed Health Corp. (TMED)
Category
Healthcare
P/S ratio for EGF Theramed Health Corp. (TMED)
P/S ratio as of 2026 TTM: 0
According to EGF Theramed Health Corp. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for EGF Theramed Health Corp. from 2026 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 1.53 | - |
US
|
|
| 65.30 | - |
AU
|
|
| 0.87 | - |
US
|
|
| 8.37 | - |
US
|
|
| 15.04 | - |
US
|
